Unknown

Dataset Information

0

Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.


ABSTRACT: Recent evidence suggests that human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) patients have better survival than HPV-negative patients. However, it is unclear if similar patterns for survival exist across different tumor sites, and whether HPV-associated prognosis is modified by type of treatment. We prospectively tested 222 histologically confirmed HNSCC primary tumors for HPV DNA by PCR and HPV E6/E7 RNA by RT-PCR prior to treatment at a large urban health center. Cox proportional hazard ratio models were constructed to assess HPV-associated differences in overall and disease-specific survival adjusting for clinical and demographic covariates. HPV detection varied significantly by primary HNSCC tumor site, from 35 % for oropharynx, to 25 % for hypopharynx, 5 % for larynx, and 3 % for oral cavity (p < 0.0001), with HPV16 accounting for the majority (95 %) of HPV-positive tumors. The hazard-risk of overall and disease-specific death comparing HPV16-positive versus negative oropharyngeal HNSCC was reduced by 74 and 89 %, respectively (p values < 0.05), and was independent of other prognostic indicators; no statistically significant changes in outcomes were observed for non-oropharyngeal HNSCC sites. Prediction of overall survival was better with combined DNA and RNA HPV16 positive PCR detection. There was no difference in HPV16-associated survival whether patients received either surgery or (chemo)radiotherapy as their initial treatment modality. Improved HPV-associated HNSCC survival is limited to patients with oropharyngeal primaries. No selective treatment advantage is observed for HPV-positive tumors, although clinical trials are needed to evaluate which treatment modalities provide the most benefit for HPV-positive HNSCC.

SUBMITTER: Salazar CR 

PROVIDER: S-EPMC3950385 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.

Salazar Christian R CR   Smith Richard V RV   Garg Madhur K MK   Haigentz Missak M   Schiff Bradley A BA   Kawachi Nicole N   Anayannis Nicole N   Belbin Thomas J TJ   Prystowsky Michael B MB   Burk Robert D RD   Schlecht Nicolas F NF  

Head and neck pathology 20130904 1


Recent evidence suggests that human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) patients have better survival than HPV-negative patients. However, it is unclear if similar patterns for survival exist across different tumor sites, and whether HPV-associated prognosis is modified by type of treatment. We prospectively tested 222 histologically confirmed HNSCC primary tumors for HPV DNA by PCR and HPV E6/E7 RNA by RT-PCR prior to treatment at a large urban health cen  ...[more]

Similar Datasets

| S-EPMC4900934 | biostudies-literature
| S-EPMC7072739 | biostudies-literature
| S-EPMC5161679 | biostudies-literature
| S-EPMC3665382 | biostudies-literature
2022-03-01 | PXD001438 | Pride
| S-EPMC5067633 | biostudies-literature
| S-EPMC6141174 | biostudies-literature
2024-09-06 | PXD055003 | Pride
| S-EPMC6728550 | biostudies-literature
| S-EPMC4317800 | biostudies-other